- You are here:
-
HNRP Home
- News
Main Menu
Quick Links
Spotlight
New Diagnostic Criteria May Enable Earlier Detection of Cognitive Impairment in Women
Alison Caldwell, UCSD Health News Release, October 9, 2019
Women make up two-thirds of patients with Alzheimer’s disease — so why is it that women are less likely than men to be diagnosed with its precursor, amnestic mild cognitive impairment (aMCI)? This was the question guiding a new study by University of California San Diego School of Medicine researchers studying how the life-long female advantage in verbal memory performance might be masking early symptoms of dementia in women.
In a study published October 9, 2019 by Neurology® , the medical journal of the American Academy of Neurology, the team studied the data of nearly 1,000 patients who participated in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and found that when verbal memory test cut-offs were tailored to patient sex, more female patients and fewer male patients were considered to have aMCI. This could change the way aMCI diagnoses are determined and make it easier to catch the condition in its early stages.
Read the rest of the article here.
Rowan Saloner received a Blue Ribbon Award!
Rowan Saloner received a Blue Ribbon Award at the 126th Annual Convention of the American Psychological Association (APA) for his presentation “Is Alcohol Neuroprotective in Methamphetamine-Associated Neuropsychological Impairment?”
He also was awarded a $750 Travel Award from the National Institute on Alcohol Abuse and Alcoholism to attend this year's APA convention in order to present his findings.
Pride and Research! San Diego Pride 2018
Staff from the HIV Neurobehavioral Research Program will co-host a booth with the AntiViral Research Center at the San Diego Pride event on July 14 and 15, 2018. Stop by and say hello! Grab one of our fabulous Pride and Research bags (while supplies last).
Erin Sundermann Promotes the Need for Sex-Specific Cut Scores in Alzheimer’s Diagnoses
Several studies presented at the 2018 Alzheimer's Association International Conference focused on how Alzheimer’s disease manifests in women. HNRP investigator Erin Sundermann reported on how women may be diagnosed with Alzheimer’s later in disease course than men due to superior verbal performance that survives into the early stages of disease. Women’s verbal compensation strategies on diagnostic tests may cause a delay in treatment. Sex-specific cut scores could enable women to access treatment earlier and improve disease progression.
HNRP at the ISNV
In 2018 the 15th International Symposium on NeuroVirology is a joint meeting with the 24th Scientific Conference of the Society on NeuroImmune Pharmacology. This will broadly bridge the fields of neurovirology, immunology, and pharmacology.
HNRP affiliated investigator presentations at the meeting explore varied aspects of HIV infection that affect cognition.